This drug-delivery system utilizes ferrocene and magnetic fields to improve controlled release in targeted therapies, suggesting a novel approach for oncological applications.
This paper reports the development of an advanced dual-stimuli-responsive drug-delivery system designed to enhance the precision and efficiency of targeted therapies. The system integrates the unique properties of ferrocene and porous iron oxide microspheres (P-Fe₂O₃) to respond to reactive oxygen species and external magnetic fields. Ferrocene, with its well-known redox properties, facilitates selective drug release in oxidative environments commonly found in tumor tissues, while P-Fe₂O₃ imparts magnetism and porosity for improved targeting and controlled release under magnetic stimuli. P-Fe₂O₃ is synthesized using an environmentally friendly, continuous, and scalable spray pyrolysis technique, whereas ferrocene-based polymers are prepared via radical polymerization. As conventional nanostructured microsphere syntheses are time intensive, use toxic acids, and face scale-up challenges, this study proposes spray pyrolysis as an efficient approach for producing well-designed porous iron oxide microspheres capable of loading ferrocene nanoparticles on a large scale. Combining these materials yields a synergistic effect, optimizing drug delivery through selective release and enhanced control mechanisms. The drug release profiles of the model compounds are assessed, underscoring the potential of this dual-response system for precise, efficient, and safe therapeutic delivery. This innovative platform demonstrates significant potential as a next-generation drug-delivery technology aimed at minimizing side effects and maximizing therapeutic outcomes in oncological applications.
No takes yet. Share an insight, caveat, or question.
Seo et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: